ScPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
ScPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
To access the new Call me feature, which avoids having to wait for an operator, click here.Management to host conference call and webcast, after-market on November 13, 2024, at 4:30 p.m. ET
管理層將於2024年11月13日下午4:30（ET）在盤後舉行電話會議和網絡直播。
BURLINGTON, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, November 13, 2024, to discuss the financial results for the third quarter 2024 and provide a business update.
馬薩諸塞州伯靈頓，2024年11月6日（全球新聞社）--scpharmaceuticals公司（納斯達克：SCPH），一家致力於通過以患者爲中心的創新改革心腎保健的藥品公司，今日宣佈，scpharmaceuticals管理層將於2024年11月13日星期三下午4:30（ET）舉行電話會議和音頻網絡直播，討論2024年第三季度的財務業績並提供業務更新。
Participants should dial 1-877-407-9208 (domestic) or 1-201-493-6784 (international) with the conference code 13749995.
參與者應撥打1-877-407-9208（國內）或1-201-493-6784（國際），會議代碼13749995。
To access the new Call me feature, which avoids having to wait for an operator, click here.
要使用新的看漲功能而不必等待運營商，請單擊此處。
The live webcast and replay of the conference call can be accessed here or under "News & Events" in the Investor Relations section of the Company's website, .
電話會議的現場網絡直播和重播可以在公司網站的「新聞與事件」下或點擊此處進行訪問。
About scPharmaceuticals
關於scpharmaceuticals
At scPharmaceuticals, we are powered by passion, driven by patient care. Our Mission is focused on advancing cardiorenal care through innovative, integrated treatments that address unmet patient needs.
在scpharmaceuticals，我們秉承熱情，致力於患者護理。我們的使命是通過創新、綜合治療來推動心臟腎臟護理，滿足患者的需求。
Our goal is to become the foremost advocate for patient-centric cardiorenal care, driving global health improvements through specialized, multidisciplinary approaches. scPharmaceuticals is expanding its reach, offering integrated therapies and products that address diverse healthcare needs and potentially improve the lives of our patients. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit .
我們的目標是成爲以患者爲中心的心臟腎臟護理的首要倡導者，通過專業的、跨學科的方法推動全球健康改善。scpharmaceuticals正在擴大其影響範圍，提供綜合療法和產品，滿足不同的醫療需求，潛在地改善患者的生活。scpharmaceuticals總部位於馬薩諸塞州的伯靈頓。欲了解更多信息，請訪問。
Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com
Katherine Miranda
scPharmaceuticals Inc.，781-301-6869
kmiranda@scpharma.com
Investors:
Nick Colangelo
Gilmartin Group, 339-225-1047
Nick@GilmartinIR.com
投資者:
Nick Colangelo
Gilmartin Group，339-225-1047
Nick@GilmartinIR.com
譯文內容由第三人軟體翻譯。
